Julie Makani/LinkedIn
May 25, 2026, 15:28
Julie Makani: African Health Science Partnerships at INTEREST 2026
Julie Makani, Science Advisor at East Central and Southern Africa Health Community, shared a post on LinkedIn:
“Meetings at the INTEREST Conference in 2026
Speakers:
- Dr Nyaradzo Mgodi, University of Zimbabwe
- Prof Julie Makani, MUHAS
Health Science in Africa: Zimbabwe and Tanzania
Discussion on potential partnership opportunities involving SickleInAfrica, ACRN, and GGTI (Global Gene Therapy Initiative), focusing on sickle cell disease (SCD) and HIV.
INTEREST 2026 in Dar-es-Salaam.
12-15 May 2026.
International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings (INTEREST Conference).”
Find more posts featuring Julie Makani on Hemostasis Today.
-
May 25, 2026, 15:31Tagreed Alkaltham: Beyond the Blood Bank Transfusion Medicine Leadership Patient Safety and Healthcare Systems
-
May 25, 2026, 15:21Michael Stark: How Glucocorticoids in Pregnancy Affect Fetal Development and Why It Matters
-
May 25, 2026, 15:01Abdirahman K. Mohamud: A New Continental Plan for Sickle Cell Disease in Africa
-
May 25, 2026, 15:00Tahsim Anwar: Highlighting Transfusion Therapy as a Cornerstone in the Management of SCD Complications
-
May 25, 2026, 14:59Nimesh Patel: Understanding Plasmapheresis – A Clinical Overview
-
May 25, 2026, 14:58Samwel Mikaye: Pathophysiology, Clinical Features and Management of CAD
-
May 25, 2026, 14:57Rupam Manna: Approach and Management of Deep Vein Thrombosis in Cancer
-
May 25, 2026, 14:56Andrea Fischer: Celebrating Hematology Advocacy Recognition and New Achievements This Spring
-
May 25, 2026, 14:45Monica Schaller: How Do Autophagy, Inflammation, and NETs Interact to Drive Autoimmune Thrombosis?